A carregar...
Design and Evaluation of Tumor-Specific Dendrimer Epigenetic Therapeutics
Histone deacetylase inhibitors (HDACi) are promising therapeutics for cancer. HDACi alter the epigenetic state of tumors and provide a unique approach to treat cancer. Although studies with HDACi have shown promise in some cancers, variable efficacy and off-target effects have limited their use. To...
Na minha lista:
| Publicado no: | ChemistryOpen |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4522184/ https://ncbi.nlm.nih.gov/pubmed/26246996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/open.201402141 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|